Stockscreener 앱 받기
9.81
0.20%
0.02
시간 외 거래:
9.81
Rxsight Inc 주식(RXST)의 최신 뉴스
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - FinancialContent
Institution Moves: What is RxSight Incs valuation compared to sectorTrade Performance Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
RxSight stock price target raised to $11.50 from $11.00 at Jefferies - Investing.com Canada
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock? - Nasdaq
RxSight Inc. (RXST) PT Raised to $11.50 at Jefferies - StreetInsider
RxSight Shows Growth in Preliminary Q4 and 2025 Results; Names Mark Wilterding as CFO - VisionMonday.com
RxSight Announces New CFO and Strong Preliminary Results - TipRanks
Stifel reiterates Hold rating on RxSight stock amid competition concerns By Investing.com - Investing.com Nigeria
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
Stifel reiterates Hold rating on RxSight stock amid competition concerns - Investing.com
RxSight Up 11% on Preliminary Q4, Full Year Results - Orange County Business Journal
RxSight stock holds steady as UBS maintains Neutral rating ahead of conference - Investing.com Nigeria
Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday - Benzinga
RxSight (RXST) Reiterated at Neutral by UBS: 'Need More Regular Signs of Come-back' - StreetInsider
RxSight (RXST) Reiterated at Hold by Stifel Amid LAL, LDD Slowdown - StreetInsider
Benign Growth For RxSight, Inc. (NASDAQ:RXST) Underpins Stock's 30% Plummet - 富途牛牛
RxSight reports Q4 revenue of $32.6 million, exceeds 2025 guidance By Investing.com - Investing.com Nigeria
RxSight guides FY revenue above previous estimates, names new CFO - MSN
RxSight Sees Q4 Revenue Above View; Names Mark Wilterding CFO - Nasdaq
RxSight reports Q4 revenue of $32.6 million, exceeds 2025 guidance - Investing.com
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer - The Manila Times
RxSight, Inc. Reports Preliminary Financial Results for Q4 and Full-Year 2025; Announces Appointment of New CFO - Quiver Quantitative
RxSight says Mark Wilterding appointed as CFO effective Jan 11, 2026 - marketscreener.com
RxSight Says Mark Wilterding Appointed As CFO Effective Jan 11, 2026 - TradingView — Track All Markets
Star Tribune - FinancialContent
RxSight, Inc. Appoints Mark Wilterding as Chief Financial Officer, Effective January 11, 2026 - marketscreener.com
We're Hopeful That RxSight (NASDAQ:RXST) Will Use Its Cash Wisely - Sahm
RxSight, Inc. (RXST) Investor Outlook: A Close Look At Its 7.98% Potential Upside - DirectorsTalk Interviews
RxSight down on CFO transition - MSN
Is RxSight Inc. stock dividend yield sustainableJuly 2025 Institutional & Stepwise Entry/Exit Trade Alerts - Улправда
Is RxSight Inc. stock trading at a premium valuation2025 Fundamental Recap & Real-Time Buy Signal Alerts - Улправда
Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - marketscreener.com
Will RxSight Inc. stock outperform international peers2026 world cup usa national team group stage playmakers possession football tactical prediction tactical review - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. ... - Bluefield Daily Telegraph
Looking At The Narrative For RxSight (RXST) After A Better Than Feared Quarter - Yahoo Finance
RxSight CFO Shelley Thunen to Step Down - Orange County Business Journal
Income Plays: Will RxSight Inc stock outperform value stocksEarnings Growth Summary & Low Risk High Win Rate Picks - moha.gov.vn
RxSight director sells $108,618 in common stock - MSN
Trading the Move, Not the Narrative: (RXST) Edition - Stock Traders Daily
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - The Manila Times
WaterWorldRxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - FinancialContent
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
Institutional Owners May Take Dramatic Actions as RxSight, Inc.'s (NASDAQ:RXST) Recent 13% Drop Adds to One-year Losses - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
RxSight, Inc. Announces Transition of Chief Financial Officer Shelley Thunen - VisionMonday.com
RxSight enters transition agreement with outgoing CFO Shelley Thunen By Investing.com - Investing.com Nigeria
RxSight enters transition agreement with outgoing CFO Shelley Thunen - Investing.com
0.42%
1.96%
자본화:
|
볼륨(24시간):